Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic EphA2 Positive Cancer”

2 trials

Showing 2 of 2 results

Testing effectiveness (Phase 2)WithdrawnNCT02575261
What this trial is testing

CAR-T Cell Immunotherapy for EphA2 Positive Malignant Glioma Patients

Who this might be right for
EphA2 Positive Malignant GliomaCAR-T Cell Immunotherapy
Fuda Cancer Hospital, Guangzhou
Early research (Phase 1)Study completedNCT02252211
What this trial is testing

Safety and Bioimaging Trial of DS-8895a in Patients With Advanced EphA2 Positive Cancers

Who this might be right for
Malignant Solid TumorMetastatic EphA2 Positive Cancer
Ludwig Institute for Cancer Research 9

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation